These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32682409)

  • 1. Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells.
    Zhang F; Liu R; Zhang H; Liu C; Liu C; Lu Y
    BMC Cancer; 2020 Jul; 20(1):673. PubMed ID: 32682409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanos3, a cancer-germline gene, promotes cell proliferation, migration, chemoresistance, and invasion of human glioblastoma.
    Zhang F; Liu R; Liu C; Zhang H; Lu Y
    Cancer Cell Int; 2020; 20():197. PubMed ID: 32508533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
    Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
    Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
    [No Abstract]   [Full Text] [Related]  

  • 4. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells.
    Li W; Jiang P; Sun X; Xu S; Ma X; Zhan R
    Cell Mol Neurobiol; 2016 Nov; 36(8):1219-1227. PubMed ID: 26983719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axis.
    Bi CL; Liu JF; Zhang MY; Lan S; Yang ZY; Fang JS
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33057597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells.
    Jiang X; Yan Y; Hu M; Chen X; Wang Y; Dai Y; Wu D; Wang Y; Zhuang Z; Xia H
    J Neurosurg; 2016 Jan; 124(1):129-36. PubMed ID: 26274999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.
    MacLeod G; Bozek DA; Rajakulendran N; Monteiro V; Ahmadi M; Steinhart Z; Kushida MM; Yu H; Coutinho FJ; Cavalli FMG; Restall I; Hao X; Hart T; Luchman HA; Weiss S; Dirks PB; Angers S
    Cell Rep; 2019 Apr; 27(3):971-986.e9. PubMed ID: 30995489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cancer-germline gene DAZL promotes progression and cisplatin resistance of non-small cell lung cancer by upregulating JAK2 and MCM8.
    Zhou L; Le MNU; Du Y; Chen X; Jin M; Xiang H; Xia LE; Zhou J; He J; Ning Y
    Gene; 2024 Jul; 916():148449. PubMed ID: 38588931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1.
    Zhu Y; Wang H; Fei M; Tang T; Niu W; Zhang L
    Mol Neurobiol; 2021 Apr; 58(4):1438-1452. PubMed ID: 33190170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
    Guerriero C; Matera C; Del Bufalo D; De Amici M; Conti L; Dallanoce C; Tata AM
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance.
    Atkins RJ; Stylli SS; Kurganovs N; Mangiola S; Nowell CJ; Ware TM; Corcoran NM; Brown DV; Kaye AH; Morokoff A; Luwor RB; Hovens CM; Mantamadiotis T
    Exp Cell Res; 2019 Jan; 374(2):353-364. PubMed ID: 30562483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
    Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I
    Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
    Yang L; Yan Z; Wang Y; Ma W; Li C
    Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
    Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
    Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e.
    Gong W; Zheng J; Liu X; Ma J; Liu Y; Xue Y
    Oncotarget; 2016 Sep; 7(38):62208-62223. PubMed ID: 27556696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.